Vinorelbine and carboplatin in inoperable non-small cell lung cancer: A monoinstitutional phase II study

Oncology

Volumn 64, Issue 2, 2003, Pages 97-101

  Cremonesi, M ^a   Mandala M ^a   Cazzaniga, M ^a   Rezzani, C ^b   Gambera, M ^a   Barni, Sandro ^a  

^a TREVIGLIO HOSPITAL   (Italy)

^b UNIVERSITY OF PAVIA   (Italy)

Author keywords

Carboplatin; Lung cancer; Vinorelbine

Indexed keywords

CARBOPLATIN; NAVELBINE;

ADULT; AGED; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER PATIENT; CANCER SURVIVAL; CONFIDENCE INTERVAL; CONTROLLED STUDY; DISEASE COURSE; DRUG EFFICACY; DRUG TOLERABILITY; ELECTROCORTICOGRAPHY; GRANULOCYTOPENIA; HEMATOLOGIC DISEASE; HUMAN; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; NAUSEA; NEUROPATHY; NEUTROPENIA; PRIORITY JOURNAL; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE; TREATMENT OUTCOME; VOMITING;

ADULT; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC AGENTS, PHYTOGENIC; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARBOPLATIN; CARCINOMA, NON-SMALL-CELL LUNG; DRUG ADMINISTRATION SCHEDULE; FEMALE; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM STAGING; SURVIVAL ANALYSIS; TREATMENT OUTCOME; VINBLASTINE;

EID: 0037261753     PISSN: 00302414     EISSN: None     Source Type: Journal    
DOI: 10.1159/000067765     Document Type: Article

References (29)

1. Non-Small Cell Lung Cancer Collaborative Group: Chemotherapy in non small cell lung cancer: A meta-analysis using updated data on individual patients from 52 randomized clinical trials. Br Med J 1995;7:899-909.
2. Kreisman H, Ginsberg S, Propert KJ, et al: Carboplatin or iproplatin in advanced NSCLC: A Cancer and Leukemia Group B study. Cancer Treat Rep 1987;71:1049-1052.
3. Klastersky J, Sculier JP, Lacroix H, et al: Randomized study comparing cisplatin or carboplatin with etoposide in patients with advanced non-small-cell lung cancer: European Organization for Research and Treatment of Cancer Protocol 07861. J Clin Oncol 1990;8:1556-1562.
4. Bonomi PD, Finkelstein DM, Ruckdeschel JC: Combination chemotherapy versus single agents followed by combination chemotherapy in stage IV non-small-cell lung cancer: A study of the Eastern Cooperative Oncology Group. J Clin Oncol 1989;7:1602-1613.
5. Mangeney P, Andriamialisoa R, Langlois Y, et al: A new class of antitumor coumponds: 5′-Nor and 5′, 6′-seco derivatives of vinblastine-type alkaloids. J Org Chem 1979;44:3765-3668.
6. Lallemand JY, Langlois N, Potier P, et al: 5′Nor-anhydrovinblastine - Prototype of a new class of vinblastine derivatives. Tetrahedon 1979;35:2175-2179.
7. Fellous A, Ohayon R, Vacassin T, et al: Biochemical effects of Navelbine on tubulin and associated proteins. Semin Oncol 1989;16(suppl 4):9-14.
8. Furuse K, Kubota K, Kawahara M, et al: A phase II study of vinorelbine, a new derivative of vinca alkaloid, for previously untreated advanced non-small cell lung cancer. Japan Vinorelbine Lung Cancer Study Group. Lung Cancer 1994;11:385-391.
9. Depierre A, Lemarie E, Dabouis G, et al: A phase II study of Navelbine (vinorelbine) in the treatment of non-small-cell lung cancer. Am J Clin Oncol 1991;14:115-119.
10. Masotti A, Borzellino G, Zannini G, et al: Efficacy and toxicity of vinorelbine-carboplatin combination in the treatment of advanced adenocarcinoma or large-cell carcinoma of the lung. Tumori 1995;81:112-116.
11. Colleoni M, Boni L, Vicario G, et al: A dose-escalating study of carboplatin combined with vinorelbine in non-small-cell lung cancer. Oncology 1996;53:364-368.
12. Kaplan EL, Meier P: Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958;53:457-481.
13. Simon R: Confidence interval for reporting results of clinical trials. Ann Intern Med 1986;105:429-435.
14. Gehan EA: The determination of the number of patients required in a preliminary and a follow-up trial of a new chemotherapeutic agent. J Chronic Dis 1961;20:346-353.
15. Silvestri G, Pritchard R, Welch HG: Preferences for chemotherapy in patients with advanced non-small cell lung cancer: Descriptive study based on scripted interviews. BMJ 1998;317:771-775.
16. Schiller J, Harrington D, Sandler A, et al: A randomized phase III trial of four chemotherapy regimens in advanced non-small cell lung cancer (NSCLC). Proc Am Soc Clin Oncol 2000;18:2.
17. Depierre A, Chastang C, Quoix E, et al: Vinorelbine versus vinorelbine plus cisplatin in advanced non small cell lung cancer: A randomized trial. Ann Oncol 1994;5:37-42.
18. Le Chevalier T, Brisgand D, Douillard J, et al: Randomized study of vinorelbine and cisplatin versus vindesine and cisplatin versus vinorelbine alone in advanced non small cell lung cancer: Results of a European multicenter trial including 612 patients. J Clin Oncol 1994;12:360-367.
19. Kelly K, Crowley J, Bunn PA, et al: A randomized phase III trial of paclitaxel plus carboplatin versus vinorelbine plus cisplatin in untreated advanced non small cell lung cancer (NSCLC): A Southwest Oncology Group (SWOG) trial. Proc Am Soc Clin Oncol 1999;18:461a.
20. Langer C, Manola J, Bernardo P, et al: Advanced age alone does not compromise outcome in fit non small cell lung cancer (NSCLC) patients (pts) receiving platinum based therapy: Implications of ECOG 5592. Proc Am Soc Clin Oncol 1999;17:1912.
21. Rosvold E, Langer CJ, McAleer C, et al: Advancing age does not exacerbate toxicity or compromise outcome in non small cell lung cancer (NSCLC) patients (pts) receiving paclitaxel-carboplatin (P-C). Proc Am Soc Clin Oncol 1999;17:1846.
22. Bretti S, Manzin E, Celano A, et al: Low dose carboplatin (AUC 4.5) combined with vinorelbine in the treatment of advanced non-small cell lung cancer: A single institution phase II study. Oncol Rep 2001;8:381-385.
23. Horvath L, Boyer M, Clarke S, et al: Carboplatin and vinorelbine in untreated locally advanced and metastatic non-small cell lung cancer. Lung Cancer 2001;32:173-178.
24. Santomaggio C, Tucci E, Rinaldini M, et al: Carboplatin and vinorelbine in the treatment of advanced non-small-cell lung cancer: A multicenter phase II study. Am J Clin Oncol 1998;21:67-71.
25. Masters G: Carboplatin and vinorelbine in advanced non-small cell lung cancer: A phase I/II study. Oncologist 2001;6(suppl 1):12-15.
26. Mountain CF: Revisions in the international system for staging lung cancer. Chest 1997;111:1710-1717.
27. Ginsberg RJ, Vokes EE, Raben A: Non small cell lung cancer; in De Vita VT Jr, Hellman S, Rosemberg SA (eds): Cancer: Principles and Practice of Oncology, ed 5. Philadelphia, Lippincott, 1997, pp 858-911.
28. Pritchard RS, Anthony SP: Chemotherapy plus radiotherapy compared with radiotherapy alone in the treatment of locally advanced, unresectable, non-small-cell lung cancer: A meta-analysis. Ann Intern Med 1996;125:723-729.
29. Vercelli M, Quaglia A, Casella C, et al: Cancer in the elderly patients: The population based indexes in Europe (incidence, mortality, survival and prevalence). Ann Oncol 1998;9:55-56.